SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001038133-21-000024
Filing Date
2021-05-06
Accepted
2021-05-06 10:12:41
Documents
16
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hska-20210506.htm   iXBRL 8-K 42543
2 EX-99.1 ex99-1earningsreleaseq12021.htm EX-99.1 188353
8 LOGO heskalogoa051.jpg GRAPHIC 45126
  Complete submission text file 0001038133-21-000024.txt   461942

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hska-20210506.xsd EX-101.SCH 2415
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hska-20210506_cal.xml EX-101.CAL 708
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hska-20210506_def.xml EX-101.DEF 1645
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hska-20210506_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hska-20210506_pre.xml EX-101.PRE 12644
9 EXTRACTED XBRL INSTANCE DOCUMENT hska-20210506_htm.xml XML 19379
Mailing Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538
Business Address 3760 ROCKY MOUNTAIN AVENUE LOVELAND CO 80538 9704937272
HESKA CORP (Filer) CIK: 0001038133 (see all company filings)

IRS No.: 770192527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22427 | Film No.: 21896262
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences